For non-alcoholic fatty liver disease, we showed similar associations when excluding participants with elevated alanine transaminase (≥33 U/L for men and ≥25 U/L for women) in a nested case–control study of ~18 000 participants with blood biochemistry data (online supplementary table 13). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.